Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) is scheduled to announce Q1 earnings results on Thursday, May 1st, before market open. The consensus EPS Estimate is -$3.79 and the consensus Revenue ...

Analysts expect Madrigal Pharmaceuticals to report an earnings per share (EPS) of $-3.83. The market awaits Madrigal Pharmaceuticals's announcement, with hopes high for news of surpassing estimates ...

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced six ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.